Φορτώνει......
Optimizing the Outcome of Anti-Myeloma Treatment with Daratumumab
A search of the scientific literature for Daratumumab and myeloma gives more than 600 results (January 2021), which reflects the interest and activity around this antibody, an interest that was also reflected by the assignment of breakthrough designation for Daratumumab as a treatment for multiple m...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Clin Med |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7958124/ https://ncbi.nlm.nih.gov/pubmed/33801271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10051002 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|